Durvalumab vs Valproic Acid

## Durvalumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Valproic Acid**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Valproic Acid**: Enhances GABA transmission and blocks sodium/calcium channels.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Valproic Acid — 9-16 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Valproic Acid — C8H16O2.

**Molecular Weight**: Durvalumab — N/A; Valproic Acid — 144.2110 g/mol.

**Type**: Durvalumab — Antibody; Valproic Acid — Small molecule.